Live
Endpoints NewsShanghai biotech Excalipoint gains $68.7M for T cell engagersBioPharma DiveChinese biotech startup Excalipoint banks $69M for next-gen T cell engagersWatersGraybill Wealth Management LTD. Makes New Investment in Waters Corporation $WAT - MarketBeatAgilentIs It Time To Reassess Agilent Technologies (A) After Its Recent Share Price Weakness - Yahoo Finance SingaporeEndpoints NewsXaira unveils AI model X-Cell for predicting virtual cellsThermo FisherThermo Fisher Scientific Inc. $TMO Shares Purchased by CIBC Private Wealth Group LLC - MarketBeatAgilentAgilent’s $950m Biocare buy: The ‘aligned’ asset for pathology innovation - BioXconomyThermo FisherThermo Fisher: A High-Quality Life Science Platform Positioned For Growth (NYSE:TMO) - Seeking AlphaAgilentAssessing Agilent Technologies (A) Valuation After Recent Share Price Weakness - Yahoo FinanceIlluminaLife Sciences Tools & Services Stocks Q4 Earnings: Illumina (NASDAQ:ILMN) Firing on All Cylinders - TradingVieweLifeAn easy way to improve lab meetingseLifeFunctional connectivity-based attractor dynamics of the human brain in rest, task, and disease
Lonza News Jan 30, 2026

Contract drug manufacturer Lonza forecasts slower sales growth for 2026 - MSN

Contract drug manufacturer Lonza forecasts slower sales growth for 2026 - MSN

Original
Body unavailable. Use the original source.

Directory

59 All